SEC Form 4 · accession 0001144204-15-015074
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles E Mather IV
Director
Period of report
Mar 10, 2015
Accepted (ET)
Mar 10, 2015 · 2:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001430306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Mar 10, 2015 | P | 1,000 | $6.80 | A | 11,830 | D |
Table II — derivative securities
No Table II lines on this filing.